Search results
Results from the WOW.Com Content Network
The Game Developers Conference (GDC) is an annual conference for video game developers.The event includes an expo, networking events, and awards shows like the Game Developers Choice Awards and Independent Games Festival, and a variety of tutorials, lectures, and roundtables by industry professionals on game-related topics covering programming, design, audio, production, business and ...
The Game Developers Choice Awards are awards annually presented at the Game Developers Conference for outstanding game developers and games. [1] Introduced in 2001, the Game Developers Choice Awards were preceded by the Spotlight Awards, which were presented from 1997 to 1999. [2]
The Game Developers Choice Award for the Game of the Year, also known as GDCA Game of the Year, is the main video game award presented at the Game Developers Conference (GDC), the largest annual gathering of professional video game developers.
23rd Game Developers Choice Awards; Date: March 22, 2023: Venue: Moscone Center: Hosted by: Leslee Sullivant: Highlights; Most awards: Elden Ring and God of War Ragnarök (3): Most nominations
Gross Dealer Concession or GDC is the revenue to a brokerage firm when commissioned securities and insurance salespeople sell a product, whether it is an investment like stocks, bonds, or mutual funds, or insurance like life insurance or long term care insurance.
The Global Digital Compact is an initiative proposed in the United Nations Secretary-General António Guterres's Common Agenda.The objective of this compact is to ensure that digital technologies are used responsibly and for the benefit of all, while addressing the digital divide and fostering a safe and inclusive digital environment.
Scheme of a solid-oxide fuel cell. A solid oxide fuel cell (or SOFC) is an electrochemical conversion device that produces electricity directly from oxidizing a fuel. Fuel cells are characterized by their electrolyte material; the SOFC has a solid oxide or ceramic electrolyte.
Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). [3] The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. [4]